Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Margin
Standard Chem & Pharm Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| TW |
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
11.3B TWD |
20%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
793.6B USD |
38%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
393.8B USD |
26%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2.3T DKK |
48%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
246.5B CHF |
32%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
235.8B USD |
36%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
180B GBP |
23%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
200.9B CHF |
32%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
166.1B USD |
11%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.9B USD |
25%
|
Standard Chem & Pharm Co Ltd
Glance View
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Standard Chem & Pharm Co Ltd's most recent financial statements, the company has Operating Margin of 20.4%.
You don't have any saved screeners yet